Non-Invasive Chromosomal Evaluation of Trisomy Study



Status:Recruiting
Conditions:Other Indications, Other Indications
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 60
Updated:4/21/2016
Start Date:April 2014
End Date:April 2016
Contact:Romielle Aquino
Email:raquino@ariosadx.com
Phone:408-209-9098

Use our guide to learn which trials are right for you!

This study is being conducted to provide clinically annotated samples to support continued
improvements in the Ariosa Test content, methodology, specimen processing and quality
control.


Inclusion Criteria:

- 1. Subject is at least 18 years old and can provide informed consent;

- 2. Subject has a viable singleton or twin pregnancy;

- 3. Subject is confirmed to be at least 10 weeks, 0 days gestation at the time of the
study blood draw;

- 4. Subject is planning to undergo CVS and/or amniocentesis for the purpose of genetic
analysis of the fetus OR the subject has already undergone CVS and/or amniocentesis
and is known to have a fetus with a chromosomal abnormality confirmed by genetic
analysis.

Exclusion Criteria:

- 1. Subject has known aneuploidy;

- 2. Subject is pregnant with more than two fetuses or has had sonographic evidence of
three or more gestational sacs at any time during pregnancy;

- 3. Subject has a fetal demise (including natural or elective reduction) identified
prior to consent;

- 4. Subject has history of malignancy treated with chemotherapy and/or major surgery,
or bone marrow transplant;
We found this trial at
3
sites
San Diego, California 92093
Phone: 760-242-1677
?
mi
from
San Diego, CA
Click here to add this to my saved trials
Chattanooga, Tennessee 37403
?
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Oaks, Pennsylvania 19456
?
mi
from
Oaks, PA
Click here to add this to my saved trials